Ma. Pfaller et al., Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program, CLIN INF D, 32, 2001, pp. S156-S167
The SENTRY Antimicrobial Surveillance Program has incorporated molecular st
rain typing and resistance genotyping as a means of providing additional in
formation that may be useful for understanding pathogenic microorganisms wo
rldwide. Resistance phenotypes of interest include multidrug-resistant path
ogens, extended-spectrum beta -lactamase (ESBL)-producing Enterobacteriacea
e, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant
enterococci, and fluoroquinolone-resistant (FQR) strains of gram-negative
bacilli and Streptococcus pneumoniae. Clusters of greater than or equal to2
isolates within a given resistance profile that are linked temporally and
by hospital location are flagged for DNA fingerprinting. Further characteri
zation of organisms with respect to resistance genotype is accomplished wit
h use of polymerase chain reaction and DNA sequencing. This process has bee
n highly successful in identifying clonal spread within clusters of multire
sistant pathogens. Between 50% and 90% of MRSA clusters identified by pheno
typic screening contained evidence of clonal spread. Among the Enterobacter
iaceae, ESBL-producing strains of Escherichia coli and Klebsiella pneumonia
e are the most common pathogens causing clusters of infection, and 50% of r
ecognized clusters demonstrate clonal spread. Clusters of Pseudomonas aerug
inosa, Acinetobacter species, and Stenotrophomonas maltophilia have been no
ted with clonal spread among patients with urinary tract, respiratory, and
bloodstream infections. Characterization of mutations in the FQR-determinin
g region of phenotypically susceptible isolates of E. coli and S. pneumonia
e has identified first-stage mutants among as many as 40% of isolates. The
ability to characterize organisms phenotypically and genotypically is extre
mely powerful and provides unique information that is important in a global
antimicrobial surveillance program.